91419-50-0

Basic information

• Product Name: Carbamic acid, (3-cyanopropyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (3-cyanopropyl)-, 1,1-dimethylethyl ester (9CI);TERT-BUTYL N-(3-CYANOPROPYL)CARBAMATE;tert-butyl (3-cyanopropyl)carbamate
• CAS NO: 91419-50-0
• Molecular Formula: C9H16N2O2
• Molecular Weight: 184.23554
• Product Categories: N-BOC
• Mol File: 91419-50-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 321.3±25.0 °C(Predicted)
• Appearance: /
• Density: 1.007±0.06 g/cm3(Predicted)
• PKA: 12.40±0.46(Predicted)
• CAS DataBase Reference: Carbamic acid, (3-cyanopropyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (3-cyanopropyl)-, 1,1-dimethylethyl ester (9CI)(91419-50-0)
• EPA Substance Registry System: Carbamic acid, (3-cyanopropyl)-, 1,1-dimethylethyl ester (9CI)(91419-50-0)

Safety Data

• Hazardous Substances Data: 91419-50-0(Hazardous Substances Data)

Upstream product

• 57294-38-9 N-(tert-butoxycarbonyl)-4-aminobutanoic acid 
• 151-50-8 potassium cyanide 
• 116861-31-5 tert-butyl N-(3-chloropropyl)carbamate 
• 91419-46-4 4-<(tert-butoxycarbonyl)amino>butanamide 
• 143-33-9 sodium cyanide 
• 1314538-55-0 potassium tert-butyl N-[(trifluorolambda-4-boranyl)methyl]carbamate 
• 107-13-1 acrylonitrile 
• 32754-99-7 4-aminobutyronitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 83948-53-2 3-bromopropylamine tert-butylcarbamate 
• 25909-68-6 [¹³C]-potassium cyanide 

Downstream Products

• 68076-36-8 1-amino-4-[(tert-butyloxycarbonyl)amino]butane 

Relevant articles and documents

Hydroaminomethylation of Olefins with Aminomethyltrifluoroborate by Photoredox Catalysis

A photocatalytic hydroaminomethylation of olefins with N-protected aminomethyltrifluoroborates has been developed. This methodology provides a new strategy for the introduction of a primary aminomethyl group onto electron-deficient C=C bonds. This reaction constitutes a facile entry into synthetically useful γ-aminobutyric acid (GABA) derivatives such as baclofen.

HETEROCYCLIC MODULATORS OF PKB

The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein Formula (I). The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

Active-site-directed enzyme-activated N-nitrosoamide inhibitors of trypsin

-